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Abstract: BolA is a ubiquitous global transcription factor. Despite its clear role in the induction
of important stress-resistant physiological changes and its recent implication in the virulence of
Salmonella, further research is required to shed light on the pathways modulated by BolA. In this
study, we resorted to untargeted 1H-NMR metabolomics to understand the impact of BolA on
the metabolic profile of Salmonella Typhimurium, under virulence conditions. Three strains of S.
Typhimurium SL1344 were studied: An SL1344 strain transformed with an empty plasmid (control),
a bolA knockout mutant (∆bolA), and a strain overexpressing bolA (bolA+). These strains were grown
in a minimal virulence-inducing medium and cells were collected at the end of the exponential and
stationary phases. The extracts were analyzed by NMR, and multivariate and univariate statistical
analysis were performed to identify significant alterations. Principal component analysis (PCA) and
partial least squares discriminant analysis (PLS-DA) of 1H-NMR data allowed the discrimination
between the metabolic profiles of these strains, revealing increased levels of acetate, valine, alanine,
NAD+, succinate, coenzyme A, glutathione, and putrescine in bolA+. These results indicate that BolA
regulates pathways related to stress resistance and virulence, being an important modulator of the
metabolic processes needed for S. Typhimurium infection.
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1. Introduction
Salmonella enterica is an intracellular pathogen in a myriad of animals. Among the different
serotypes, Salmonella enterica serovar Typhimurium is one of the primary sources of gastrointestinal
disease and bacteraemia in humans [1,2]. A successful infection is determined by its capacity to invade
cells and replicate intracellularly, which is driven by the activity of virulence factors encoded in the S.
Typhimurium genome [3]. These bacterial proteins are delivered to the cytosol of the host via type
III secretion systems. Of particular importance are the delivery systems encoded in the Salmonella
pathogenicity islands 1 and 2 (SPI-1 and SPI-2), which are essential for invasion and intracellular
survival [4,5]. Control and coordination of all the necessary virulence elements during infection
are achieved by intricate regulatory networks, of which many regulators have been described [6–8].
Because the virulence of Salmonella is, in part, determined by the ability to form biofilms and the
capacity to sustain stresses, such as lack of nutrients and acidic environments, important regulators of
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these processes could play a significant role in the pathogenesis of Salmonella. One such regulator is
the transcription factor BolA.
Originally found in Escherichia coli, BolA has been shown to be present in both prokaryotes and
eukaryotes [9,10]. Initial studies of bolA established it as a morphogene upregulated at the onset
of stationary growth phase, whose overexpression led to the acquisition of a spherical shape by
cells [11,12]. It was later shown that bolA acted as a major stress-response gene and that its expression
could be triggered during the exponential phase, if cells were exposed to carbon starvation and other
stressful conditions such as oxidative, acidic, or osmotic stresses [13]. The pleiotropic effect of BolA
in the cell is revealed by the important stress-resistant physiological changes that it induces. These
include a decrease in the surface to volume ratio, due to changes in morphology [11], reduction of
outer membrane permeability [14], and promotion of biofilm development [15,16]. In addition, the
involvement of BolA in the pathogenesis of S. Typhimurium has been recently confirmed in a study
involving the infection model Galleria mellonella, which showed that the production of BolA increased
the virulence of this bacteria [17]. Moreover, BolA-like proteins have been widely established as key
players in iron metabolism [18–22]. In both prokaryotic and eukaryotic organisms, BolA proteins
are closely related with CGFS-type monothiol glutaredoxins (Grxs) [10,23]. Previous studies have
demonstrated that BolA and monothiol Grxs form heterocomplexes involved in regulating Fe-S cluster
trafficking and assembly [18,23–25]. S. Typhimurium encodes other BolA homologue, IbaG, described
in E. coli as an acidic stress response protein [26]. Interestingly, IbaG was also shown to co-express
with monothiol Grxs forming heterodimers that are involved in Fe-S assembly and trafficking, which
clearly show the crucial role of BolA-like proteins in iron metabolism [27].
Despite considerable progress, further research effort is required to shed light on the pathways
modulated by BolA. The use of a holistic approach, like metabolomics, could provide further insight
into the matter. Metabolomics consists of the profiling and analysis of metabolites in biological
samples. Its application to microorganisms can result in important knowledge, which, integrated
with other “omics”, such as transcriptomics and proteomics, can provide better understanding of
cell physiology [28]. Metabolomics studies of S. Typhimurium have had a wide range of purposes,
such as studying biofilm development [29,30], discovering biomarkers for diagnostic purposes [31], or
exploring the metabolic processes connected to virulence [32]. A study combining metabolomics and
genome-scale modelling found an accumulation of amino acids, along with an increase in putrescine
levels in S. Typhimurium under virulence-inducing conditions [33]. The contribution that metabolomics
can provide to the understanding of pathogenesis, together with the discovery of BolA as a relevant
player in the virulence of S. Typhimurium, led us to the objective of this work: To study the impact
of BolA on the metabolic profile of S. Typhimurium, when grown in a virulence-inducing medium.
Due to the growth-dependent regulation of bolA, cells were collected at the end of the exponential
phase and stationary phase. 1H-NMR metabolomics was used to characterize the corresponding
intracellular metabolomes.
2. Results
2.1. Influence of BolA on the Growth of Salmonella Typhimurium in a Virulence-Inducing Medium
To evaluate the effect of BolA on the growth of Salmonella Typhimurium, cells were grown in a
minimal virulence-inducing medium (LPM medium). Initially, four strains were surveyed: A wild
type strain (WT), a WT strain transformed with an empty pWSK29 plasmid (here referred as control),
a bolA knockout mutant (∆bolA), and a strain overexpressing bolA in pWSK29 (bolA+). The strains
displayed similar growth rates (Figure 1). The WT and control strains displayed identical growth and
metabolic profiles (Figure S1). Since these two strains showed the same behavior, only the control was
used in the following study to guarantee that any possible effects observed on the metabolic profiles
were due to the overexpression of bolA and not because of the pWSK29 plasmid presence.
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Figure 1. The growth curve in minimal virulence-inducing medium (LPM medium). BolA+ reaches 
the highest optical density, followed by the control and ΔbolA strains. The presented growth curves 
are the result of three independent growths. The arrows indicate the time of cells’ collection at end of 
exponential (EE) and stationary phase (ST). 
Considering that bolA expression is upregulated in the late stages of growth [12], cells were 
collected at the end of the exponential phase (EE) and stationary phase (ST), 5 and 8 hours into 
growth, respectively. At these time points, cell morphology was assessed, revealing that bolA+ had 
acquired a spherical shape and thus confirming that this strain was overexpressing the morphogene 
bolA (Figure S2). 
2.2. 1H-NMR Metabolic Profiles of Salmonella Strains 
In the 1H-NMR spectra of the intracellular extracts of S. Typhimurium, obtained during the ST 
phase, it was possible to identify 22 metabolites, 2 exogenous compounds, and protein signals, 
which were present in all the analyzed samples (Figure 2, Table S2). 1H-NMR spectra of the EE phase 
displayed similar profiles, though the intensity of the resonances was attenuated when compared to 
those of the ST phase (not shown).  
 
Figure 2. Typical 1H-NMR acquired with an 800 MHz spectrometer. Spectrum representative of a 
sample of Salmonella Typhimurium grown in LPM medium. Legend: 1, coenzyme A; 2, isoleucine; 3, 
leucine; 4, valine; 5, lactate; 6, alanine; 7, putrescine; 8, acetate; 9, glycoprotein N-acetyl groups; 10, 
glutamine; 11, glutamic acid; 12, pyruvate; 13, succinate; 14, glutathione; 15, methionine; 16, MES 
buffer (exogenous); 17, methanol (exogenous); 18, NAD+; 19, glycogen; 20, UMP; 21, AMP; 22, 
nicotinamide ribotide; 23, histidine; 24, NADP+; 25, formate. 
2.3. Multivariate and Univariate Analysis of 1H-NMR Data 
Figure 1. The growth curve in minimal virulence-inducing medium (LPM medium). BolA+ reaches
the highest optical density, followed by the control and ∆bolA strains. The presented growth curves
are the result of three independent growths. The arrows indicate the time of cells’ collection at end of
exponential (EE) and stationary phase (ST).
Considering that bolA expression is upregulated in the late stages of growth [12], cells were
collected at the end of the exponential phase (EE) and stationary phase (ST), 5 and 8 hours into
growth, respectively. At these time points, cell morphology was assessed, revealing that bolA+ had
acquired a spherical shape and thus confirming that this strain was overexpressing the morphogene
bolA (Figure S2).
2.2. 1H-NMR Metabolic Profiles of Salmonella Strains
In the 1H-NMR spectra of the intracellular extracts of S. Typhimurium, obtained during the
ST phase, it was possible to identify 22 metabolites, 2 exogenous compounds, and protein signals,
which were present in all the analyzed samples (Figure 2, Table S2). 1H-NMR spectra of the EE phase
displayed similar profiles, though the intensity of the resonances was attenuated when compared to
those of the ST phase (not shown).
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2.3. Multivariate and Univariate Analysis of 1H-NMR Data
To assess the existence of differences between the metabolic profiles of the control, ∆bolA and bolA+
strains, 1H-NMR data from both the EE and ST phases were analyzed resorting to principal component
analysis (PCA) (Figure 3). The resulting scores plot immediately revealed a clear separation between
bolA+ and the remaining strains in both phases. Therefore, the overproduction of BolA was inducing
significant metabolic variation in S. Typhimurium. The PCA analysis also showed no separation
between the control and ∆bolA strains. However, a supervised multivariate analysis, partial least
squares discriminant analysis (PLS-DA), exposed an additional separation between the control and
∆bolA clusters in ST growth phase (Figure 4a). No separation between the control and ∆bolA groups
was observed in the PLS-DA of the EE phase (Figure S3a). Permutation analysis validated the PLS-DA
models of both the EE and ST growth phases, exhibiting predictive capabilities (Q2) of 0.599 and 0.758,
respectively (Figure S4).
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Figure 4. Partial least squares discriminant analysis (PLS-DA) model and variable importance in
projection (VIP) analysis of the control, ∆bolA and bolA+ strains in the stationary phase. (a) Scores
scatter plot of PLS-DA model of control (n = 10), ∆bol ( 10), a bol + (n = 16) samples in
the stationary phase (R2X = 0.821, R2Y = 0.939, Q2 = 0.758). (b) VIP analysis of loading weights
derived from component 1 of the PLS-DA model reveals th metabolites that contribute the most to
the discrimination observed in the scores scatter l t. : , ; 2, valine; 3, al nine; 4,
putrescine; 5, acetate; 6, glutathione; 7, succinate; 8, unk own compound(s); 9, NAD+.
The loadings resulting from the PLS-DA model, along with the implementation of the variable
importance in projection (VIP), were used to estimate the significance of each metabolite in the
discriminations observed in the PLS-DA scatter plots. The VIP scores of the EE growth indicated
increased levels of acetate, alanine, formate, glutathione, putrescine, succinate, and valine in the bolA+
strain and increased levels of glycogen, glycoprotein N-acetyl groups, and of an unknown singlet
located at 2.22 ppm in the control and ∆bolA groups (Figure S3b). The VIP analysis of loading weights
derived from component 1 of the ST growth phase revealed that bolA+ could be separated from the
remaining strains based on differences in acetate, alanine, coenzyme A, glutathione, NAD+, putrescine,
succinate, and valine, which were increased in the bolA+ strain (Figure 4b). In addition, VIP scores
derived from component 3 of the ST phase allowed discrimination between the control and ∆bolA
(Figure S5). In both growth phases, unidentified NMR resonances at 3.4 and 4.0 ppm, had higher levels
in the control and ∆bolA groups. These metabolic variations were further evaluated by univariate
analysis, which exposed the metabolic variations observed in EE phase as nonsignificant, but validated
the altered metabolites found in the ST phase. (Figure S6 and Figure 5). Acetate, alanine, coenzyme
A, glutathione, NAD+, putrescine, succinate, and valine were found to be significantly altered in the
bolA+ strain during the ST growth phase.
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3. Discussion
BolA is a global transcription factor capable of inducing significant physiological changes in
Escherichia coli. Its overproduction induces round morphology, promotion of biofilm development, and
a decrease in the permeability of the outer membrane [11,13,14]. Although bolA is a well-established
stress-response gene in E. coli, the role of its homologue in Salmonella Typhimurium is only starting to
be assessed. In the infection model Galleria mellonella, the deletion of bolA led to lower intracellular
replication and consequent decrease in the virulence of S. Typhimurium [17]. To further understand
how BolA might be modulating the metabolism of S. Typhimurium in a virulence scenario, we sought
to use 1H-NMR metabolomics to explore the metabolic variations between different strains expressing
bolA in a minimal virulence-inducing medium (LPM medium).
The impact of BolA on the metabolic signature of each strain was assessed by analysis of the
1H-NMR spectra. Independently of being the EE or the ST phase, principal component analysis
(PCA) of 1H-NMR data disclosed identical results. The evident discrimination between bolA+ and the
remaining two strains implied that BolA overproduction significantly altered the metabolic profile of S.
Typhimurium. Together with the existence of a cluster containing the control and ∆bolA strains, PCAs
suggest that the overexpression of bolA has a greater effect on cell metabolism, when compared to the
deletion of this gene.
Partial least squares discriminant analysis (PLS-DA) of the EE phase showed similar results to
those of the corresponding PCA, whereas the model obtained for the ST phase exposed the control and
∆bolA groups as having distinct metabolic profiles (Figure 4a). These results indicate that while at the
onset of stationary phase the expression of bolA in the control strain might have minimal influence on
cell metabolism, the upregulation of this morphogene as conditions become more strenuous leads to
significant metabolic changes.
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Loadings derived from both models were subjected to a variable importance in projection (VIP)
analysis, which allied to additional validation by univariate analysis allowed the identification of
the metabolites whose levels varied between strains in the EE and ST data sets. Analysis of the EE
phase suggested important metabolic variations between bolA+ and the control and ∆bolA groups.
These included altered levels of 10 metabolites and of a signal characteristic of N-acetyl groups of
glycoproteins. However, further evaluation by univariate analysis exposed most of these metabolic
variations as nonsignificant (Figure S5). A closer look into some of the metabolites involved in these
nonsignificant comparisons, such as succinate, valine, or formate, show a strong tendency for variation
between strains. Yet, data dispersion in the same condition, as seen by the outliers and long ranges
of the plots, could be contributing to the absence of significant statistical relationship between the
analyzed variables. The greater metabolic and physiological changes associated with the EE growth
phase transition could be responsible for the high variation observed in samples, turning metabolomics
analysis of this phase more prone to error than the more stable ST phase. Nonetheless, putrescine was
clearly increased in bolA+ and significant variation was present in metabolites, such as alanine and
glutathione, which are decreased in the control strain.
Analysis of the loadings derived from the PLS-DA of the ST phase led to the identification of eight
significantly altered metabolites, which shared the peculiarity of being increased in bolA+ compared to
the other strains. These metabolites included cofactors (coenzyme A and NAD+), amino acids (alanine
and valine), acetate, glutathione, putrescine, and succinate. Of these, coenzyme A, NAD+, putrescine,
and succinate were not only significantly increased in bolA+ relatively to the remaining strains, but
also increased in the control strain when compared to ∆bolA, suggesting a positive correlation between
the expression of bolA and the levels of these metabolites in the cell.
The peptidoglycan layer, located in the periplasmic space of gram-negative bacteria, is responsible
for maintaining cell shape, and amino acids such as D-alanine and D-glutamic acid are essential
components of this polymer [34]. Peptidoglycan insertion is regulated by MreB, a eukaryotic actin
homologue responsible for rod-shape maintenance. Chemical inactivation of mreB has been shown to
induce a round morphology in Salmonella [35]. Interestingly, BolA overproduction induces a spherical
morphology and high levels of this protein have been shown to reduce the levels of MreB in Escherichia
coli [36]. Additionally, production and release of D-amino acids into the growth medium have been
reported during the stationary phase in a variety of bacterial species. The specific D-amino acids
identified in these secretions varied between species, but these molecules seemed to regulate cell wall
synthesis and composition [37]. Finally, in a previous study, it was also shown the importance of
BolA in the peptidoglycan biosynthesis pathways [38]. Thus, we propose that in S. Typhimurium
the observed increase in the intracellular pools of valine and alanine could be the consequence of an
intricate network involving BolA and MreB, culminating in a process of peptidoglycan remodeling
during stationary phase.
The increased levels of acetate could be linked to overflow metabolism. This process occurs when
acetyl-coenzyme A is directed to mixed acid fermentation, with consequent production of acetate. It
has been shown that the energy necessary for the replication of S. Typhimurium, in some epithelial and
macrophage cell lines, is generated primarily by overflow metabolism to acetate and lactate [32]. In
addition, acetate has been found to promote SPI-1 expression [39]. The link between these mechanisms
and virulence, together with the overexpression of bolA, strengthen the role of this gene as a promotor
of Salmonella pathogenesis.
A positive correlation seems to exist between the levels of succinate, coenzyme A, and NAD+ and
the expression of bolA (Figure 5). NAD+ is a critical oxidizing agent in key steps of both glycolysis
and citric acid cycle (CAC) and increased concentration of this cofactor in the cytosol promotes
glycolysis [40]. Given the pivotal role of NAD+, coenzyme A, and succinate in the central metabolism,
increased levels of these metabolites must indicate higher glycolytic and CAC fluxes.
The increased levels of glutathione and putrescine in the bolA+ are particularly interesting, as
these molecules are known to confer protection to a variety of stresses. Glutathione provides resistance
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to osmotic and oxidative stresses, as shown by the role of this tripeptide in the osmoadaptation of E. coli
and the resistance to hydrogen peroxide during the stationary phase [41,42]. Another important role of
glutathione is in the cell iron homeostasis and the protection of the Fe-S proteins, which interconnects
with the regulatory role of BolA-like proteins in iron metabolism [25,42,43]. The positive correlation
between BolA and the glutathione levels in Salmonella indicates that BolA have an important role in
iron homeostasis in this organism that should be further studied. Putrescine was already reported
in a metabolomics study as being accumulated in virulence-inducing conditions [33]. Putrescine is a
polyamine whose synthesis can occur either by conversion of agmatine or conversion of L-ornithine.
Polyamines have been reported to decrease the permeability of the outer membrane in E. coli by binding
to the OmpC and OmpF porins [44]. It has also been previously reported that the overexpression of
bolA leads to a permeability decrease of the outer membrane by upregulating the production of OmpC,
a less permeable porin compared to OmpF [14]. Thus, the mechanisms by which polyamines and
BolA decrease OM permeability are distinct. Nonetheless, as a transcription factor with pleiotropic
effects in the cell, BolA could participate in the regulation of two different mechanisms with the same
goal. Polyamines have also been shown to be essential in the case of nitrosative stress. Inhibition
of growth has been documented in mutants of S. Typhimurium for polyamine biosynthesis, upon
addition of reactive nitrogen species (RNS) to the growth medium. Genetic complementation of the
speB gene, needed for putrescine biosynthesis, restored normal growth [45]. RNS, such as nitric oxide,
have antimicrobial roles and are employed by infected macrophages as a weapon against intracellular
pathogens [46]. Higher levels of putrescine, brought about by the overproduction of BolA, could
thus contribute to the resistance to RNS in the context of infection. Of additional importance is the
implication of polyamines as essential for the virulence of S. Typhimurium. Both the capacity to invade
epithelial cells and intracellular replication were reported to significantly decrease in mutants of S.
Typhimurium for polyamine biosynthesis. Further experiments revealed decreased levels of expression
of SPI-1 and SPI-2 genes, necessary for the processes of invasion and intracellular survival. Moreover,
invasion was slightly enhanced and replication significantly improved by complementation with the
speB gene [47]. Interestingly, a later study revealed that spermidine, a polyamine that derives from
putrescine, plays an important role in intracellular replication of S. Typhimurium [45]. BolA has been
recently discovered to contribute to the intracellular survival of S. Typhimurium during infection,
thereby promoting virulence [17]. An association between BolA and polyamine biosynthesis may thus
exist. A plausible hypothesis is the regulation of speB or of a gene further upstream in the biosynthetic
pathway of putrescine.
4. Materials and Methods
4.1. Bacterial Strains and Plasmids
All strains and plasmids used in this work are indicated in Table S1. All Salmonella strains are
isogenic of S. Typhimurium strain SL1344 [48]. The bolA knockout mutant strain (∆bolA) was described
in a previous study [17]. To obtain the strain overexpressing bolA (bolA+), the pRMA04 plasmid was
used to transform electrocompetent SL1344 cells. The control strain was obtained by transforming
SL1344 electrocompetent cells with the backbone plasmid pWSK29.
4.2. Growth Conditions
For metabolomics experiments, cells were grown overnight in lysogeny broth (LB) medium,
consisting of 1% sodium chloride, 1% tryptone, and 0.5% yeast extract, at 37 ◦C and 220 rpm. Afterwards,
cells were transferred to a minimal and virulence-inducing, low phosphate, low magnesium medium
(LPM), consisting of 0.5 µM ammonium ferric citrate, 8 µM MgCl2, 7.5 mM (NH4)2 SO4, 0.5 mM K2SO4,
5 mM KCl, 0.4% glucose (w/v), 0.00001% thiamine (w/v), 337 µM H3PO4, and 80 mM 2-(N-morpholino)
ethanesulfonic acid (MES) at pH 5.8 [33]. Since Salmonella Typhimurium SL1344 is auxotroph for
histidine, LPM medium was supplemented with 257.8 µM of histidine. Antibiotics were used with
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the following concentrations: 90µg/mL streptomycin, 25µg/mL chloramphenicol, and 100 µg/mL
ampicillin or its analogue carbenicillin.
4.3. Sample Preparation for Metabolomics Analysis (NMR)
Single colonies of each strain (WT, ∆bolA, bolA+, and WT-pWSK29) were taken from an agar plate,
transferred to 20 mL of LB, and incubated overnight at 37 ◦C, 220 rpm. The overnight cultures were
centrifuged at 4000 g for 10 min at 4 ◦C. The supernatants were discarded; cell pellets were washed
in 15 mL of LPM (4 ◦C) and centrifuged at 4000 g for 10 min at 4 ◦C [33]. The supernatants were
discarded and cell pellets were resuspended, for a second time, in 15 mL of LPM (4 ◦C). The optical
densities at 600 nm (OD600) were measured and used to inoculate 350 mL of LPM medium at an initial
OD600 of 0.1. Each 350 mL culture was split into three volumes of 100 mL (two volumes for metabolite
extraction at two distinct points of growth; one volume to measure OD600 along growth) and incubated
at 37 ◦C, 220 rpm. Sample collection occurred at two points in time: 5 hours (end of exponential phase)
and 8 hours (stationary phase) after inoculation (0 hours). For each time point, 2 × 45 mL of culture,
corresponding to the strain with the lowest measured OD600 (∆bolA), were collected. The volumes
collected for the remaining strains were normalized according to the OD600 of ∆bolA. Once cells were
harvested, these were immediately transferred to a bath at −35 ◦C (JULABO FP50-HE) for 2.5 min. The
suspensions were centrifuged at 3600 g for 8 min at 4 ◦C and the supernatants were discarded. Cell
pellets were washed in 40 mL of 1 × phosphate buffer (4 ◦C, pH 5.8) and centrifuged at 3600 g for 8 min
at 4 ◦C. After supernatants were discarded, cell pellets were suspended in 900 µL of an extraction
solvent consisting of methanol/chloroform/water (3:1:1, −80 ◦C) (EMSURE®Merck) and submitted to
three freeze-thaw cycles using liquid nitrogen [49]. The extracted samples were centrifuged at 12,900 g
for 10 min at 4 ◦C. The supernatants were collected and the extraction was performed a second time.
The resulting samples (1.8 mL) were concentrated using a speed-vacuum concentrator (SavantTM). A
schematic representation of the metabolite extraction protocol can be seen in Figure 6. Dried samples
were dissolved in 572 µL of D2O and 116.5 µL of potassium phosphate buffer 0.35 M at pH 7.0 in
D2O with 2 mM NaN3. Then, 11.5 µL of 2.95 mM in D2O were added, adding up to a total of 700 µL.
Subsequently, 600 µL of each sample were transferred to a 5 mm NMR tube.Metabolites 2019, 9, 243 9 of 13 
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4.4. NMR Acquisition
NMR spectra were acquired on a Bruker Avance II+ 800 MHz spectrometer equipped with a
5 mm TXI-Z H/C/N/-D probe. All 1D 1H were acquired at 298.15 K and using a noesygppr1d pulse
program, in which water presaturation occurred during mixing time and relaxation delay. Acquisition
parameters are the following: 256 scans, relaxation delay of 4 s, mixing time of 10 ms, spectral width of
16,025.641 Hz. Size of free induction decay (FID) was 128k points. Processing of spectra was performed
with Bruker TopSpin 3.2. All FID were multiplied by an exponential function, followed by Fourier
Transformation. Spectra were manually phased and baseline corrected. Chemical shifts were adjusted
according to the chemical shift of trimethylsilylpropanoic acid (TSP) at 0.00 ppm. For the purpose of
spectral assignment, 2D NMR spectra were acquired for some samples: 1H-1H TOCSY (dipsi2esgpph
pulse sequence, 512 points in F1 and 2048 points in F2; 128 scans; relaxation delay of 1.5 s; mixing time
of 60 ms; sweep width of 8012.12 Hz for both dimensions); 1H-13C HSQC (hsqcetgpsisp2 pulse sequence,
512 points in F1 and 2048 points in F2; 128 scans; relaxation delay of 1.5 s; sweep width of 33,207.441 Hz
in F1 and 12820.513 Hz in F2) and 1H J-resolved (jresgpprqf pulse sequence, 100 points in F1 and 8192
points in F2; 16 scans; relaxation delay of 2 s; sweep width of 78.113 Hz in F1 and 133,68.984 in F2).
4.5. H NMR Data Analysis
All processed 1D 1H NMR spectra were grouped and transformed into a matrix (each column
was a spectrum, each row was one of the 128k points that makes up the FID). The spectra were aligned
and centered according to the chemical shift of TSP at 0.00 ppm. The region of water (4.70–4.95 ppm)
was removed, as well as peaks resulting from exogenous compounds: MES (2.670–2.770 ppm;
2.910–2.955 ppm; 3.152–3.195 ppm; 3.740–3.82 ppm) and methanol (3.34–3.38 ppm). After trimming
the interfering peaks, only the region between 0.15–10.00 ppm was used. A binning of 8 points was
conducted, for the purposes of data reduction, and spectra were normalized by total spectral intensity.
All the aforementioned steps were completed using R software environment for statistical computing
(version 3.3.2). Principal component analysis (PCA) and partial least squares discriminant analysis
(PLS-DA) were performed using SIMCA 13.0.3. The 7-fold cross-validation method was used to
evaluate the goodness of prediction (Q2) value of the resulting models, with a permutation analysis to
further confirm the validity of the PLS-DA model. Briefly, the spectral matrix was divided into 7 blocks.
In every cross-validation round, one block is left out (validation set) and a model is generated with the
remaining spectra (training spectra). The cross-validation parameters were obtained by predicting the
class of the samples in the validation set. The process was then repeated 7 times to derive the final
cross-validation parameters of the model. To understand which metabolites were contributing the
most to the separation observed in the PLS-DA, a variable importance in projection (VIP) analysis
was conducted using the loadings derived from the PLS-DA. The metabolites responsible for the
discrimination between groups of samples were also analyzed by univariate analysis. Briefly, the areas
of the peaks corresponding to these metabolites were integrated and normalized by the total intensity
of the corresponding spectrum. Pairwise comparisons were conducted using the Wilcoxon rank-sum
test to look for significant differences (p < 0.05) between the groups of samples. Correction for multiple
testing was performed using the Benjamini-Hochberg procedure.
4.6. Microscopy Analysis
For microscopy analysis, the strains WT-pWSK29, ∆bolA, and bolA+ were grown, independently,
in 50 mL of LPM medium. Cells were collected at 4 different time points: 1, 3, 5, and 8 hours. Once
collected, cells were spun at 3600 g for 8 min and suspended in 100 µL of fresh LPM medium. Cells
were observed with a phase-contrast microscope (Leica DM6000B) with a 100x oil objective.
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5. Conclusions
Our data strengthens the role of bolA as an important stress-response gene and provides further
evidences of BolA role as an enhancer of virulence in Salmonella Typhimurium. The overexpression
of the bolA gene, under virulence-inducing conditions, led to increased pools of eight metabolites:
Acetate, valine, alanine, NAD+, succinate, coenzyme A, glutathione, and putrescine, all of which are
involved in pathways related to stress resistance and virulence. Further studies are warranted to shed
more light into the metabolic pathways affected by BolA overexpression in S. Typhimurium in relation
to virulence. However, our data support BolA as an important player of the metabolic remodeling in
the virulence process of S. Typhimurium.
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